Highly potent inhibitors of the Grb2-SH2 domain
- 1 January 1999
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 9 (2) , 221-226
- https://doi.org/10.1016/s0960-894x(98)00701-x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Structure-Based Design and Synthesis of High Affinity Tripeptide Ligands of the Grb2-SH2 DomainJournal of Medicinal Chemistry, 1998
- Structural basis for the high affinity of amino-aromatic SH2 phosphopeptide ligandsJournal of Molecular Biology, 1998
- Potent Antagonists of the SH2 Domain of Grb2: Optimization of the X+1 Position of 3-Amino-Z-Tyr(PO3H2)-X+1-Asn-NH2Journal of Medicinal Chemistry, 1998
- Structure-Based Design of a Novel Series of Nonpeptide Ligands That Bind to the pp60src SH2 DomainJournal of the American Chemical Society, 1997
- Design, Synthesis, and Cocrystal Structure of a Nonpeptide Src SH2 Domain LigandJournal of Medicinal Chemistry, 1997
- Protein tyrosine kinase inhibitors in cancer treatmentExpert Opinion on Therapeutic Patents, 1997
- Targeting signal transduction in the discovery of antiproliferative drugsChemistry & Biology, 1996
- Controlling Epidermal Growth Factor (EGF)-stimulated Ras Activation in Intact Cells by a Cell-permeable Peptide Mimicking Phosphorylated EGF ReceptorJournal of Biological Chemistry, 1996
- Design and Synthesis of 1-Aminocycloalkane-1-carboxylic Acid-Substituted Deltorphin Analogues: Unique δ and μ Opioid Activity in Modified PeptidesJournal of Medicinal Chemistry, 1996
- Synthesis of 1-(3-aminopropyl)indoles and 3-indol-1-ylpropionic acidsJournal of the Chemical Society C: Organic, 1967